Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP

Méndez-Herrera, Armando; Arias-Toledo, Eloísa; Sánchez-Alemán, Miguel; Olamendi-Portugal, Ma. Leonidez; Ruiz-Gómez, Juan; Díaz-Ortega, José Luis.
Salud pública Méx ; 60(1): 71-76, Jan.-Feb. 2018. tab
Artículo en Español | LILACS | ID: biblio-903846

Documentos relacionados

  1. [[Antibody prevalence to mumps in children and adolescents at two years of the introduction of the MMR vaccine]].
  2. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
  3. Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study.
  4. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
  5. Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.
  6. Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.
  7. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
  8. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
  9. [Meta analysis on mumps virus seroprevalence and evaluation of immunization effect in Chinese healthy population].
  10. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid.